Lunit
AI cancer screening platform detecting lung and breast cancer with high sensitivity across 40+ countries.
Why choose Lunit
Lunit is an AI medical imaging analytics company that develops algorithms for cancer screening and treatment response prediction. Its flagship products Lunit INSIGHT CXR and Lunit INSIGHT MMG help radiologists detect lung cancer and breast cancer with industry-leading sensitivity, deployed across hospitals in 40+ countries.
- Global deployment in 40+ countries
- High sensitivity cancer detection
- CE-marked and FDA-cleared
- Proven clinical impact
Where it falls short
- Focused on specific cancer types
- Enterprise pricing
- Integration complexity in some markets
Best for these users
Pricing overview
Key features
Alternatives to Lunit
DeepMind's AI that predicts protein structures with atomic accuracy, transforming drug discovery.
Microsoft's ambient clinical AI that auto-generates structured notes from patient conversations.
AI voice assistant that automates clinical documentation for healthcare professionals.
Related comparisons
The verdict
Lunit is a solid choice for business teams who need global deployment in 40+ countries. At paid, it delivers good value. Main caveat: focused on specific cancer types. Compare with alternatives before committing.